このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Fulgent Genetics マネジメント
マネジメント 基準チェック /24
Fulgent Genetics'の CEO はMing Hsiehで、 May2016年に任命され、 の在任期間は 8.08年です。 の年間総報酬は$ 5.31Mで、 18.8%給与と81.2%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の29.15%を直接所有しており、その価値は$ 170.25M 。経営陣と取締役会の平均在任期間はそれぞれ4.3年と3.3年です。
主要情報
Ming Hsieh
最高経営責任者
US$5.3m
報酬総額
| CEO給与比率 | 18.8% |
| CEO在任期間 | 8.1yrs |
| CEOの所有権 | 29.1% |
| 経営陣の平均在職期間 | 4.3yrs |
| 取締役会の平均在任期間 | 3.3yrs |
経営陣の近況
Recent updates
Fulgent Genetics: Growth Is Returning
Jun 06Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package
May 10
Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 07Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Fulgent Genetics (NASDAQ:FLGT) Has A Rock Solid Balance Sheet
Jan 25Fulgent Genetics: Improving Outlook, But Shares Aren't Quite A Buy
Jan 09Fulgent Genetics: Undervalued, High Growth, And A COVID Hedge To Boot
Dec 20CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$166m |
| Dec 31 2023 | US$5m | US$1m | -US$168m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$26m |
| Dec 31 2022 | US$5m | US$948k | US$143m |
| Sep 30 2022 | n/a | n/a | US$272m |
| Jun 30 2022 | n/a | n/a | US$392m |
| Mar 31 2022 | n/a | n/a | US$461m |
| Dec 31 2021 | US$6m | US$664k | US$507m |
| Sep 30 2021 | n/a | n/a | US$569m |
| Jun 30 2021 | n/a | n/a | US$493m |
| Mar 31 2021 | n/a | n/a | US$417m |
| Dec 31 2020 | US$248k | US$240k | US$214m |
| Sep 30 2020 | n/a | n/a | US$48m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | -US$459k |
| Dec 31 2019 | US$240k | US$240k | -US$411k |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$240k | US$240k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$6m |
| Mar 31 2018 | n/a | n/a | -US$5m |
| Dec 31 2017 | US$240k | US$240k | -US$3m |
報酬と市場: Mingの 総報酬 ($USD 5.31M ) は、 US市場 ($USD 2.45M ) の同規模の企業の平均を上回っています。
報酬と収益: Mingの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Ming Hsieh (68 yo)
8.1yrs
在職期間
US$5,309,167
報酬
Mr. Ming Hsieh has been an Independent Director of Fortinet, Inc. since April 2013. He is the Founder of Fulgent Genetics, Inc. and had been its President until May 2022 & serves as its Chief Executive Off...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 8.1yrs | US$5.31m | 29.15% $ 172.5m | |
| COO & President | 6.2yrs | US$1.79m | 1.38% $ 8.2m | |
| Chief Financial Officer | 8.4yrs | US$1.78m | 0.38% $ 2.2m | |
| Chief Scientific Officer & Laboratory Director | 7.8yrs | US$1.49m | 2.83% $ 16.7m | |
| General Counsel & Chief Privacy Officer | 2.1yrs | データなし | データなし | |
| VP of Operations & Compliance and GM of Houston Office | 3.7yrs | データなし | データなし | |
| Vice President of Business Development & Sales | 9.4yrs | データなし | データなし | |
| Vice President of Human Resources | 2.1yrs | データなし | データなし | |
| Chief Commercial Officer | 4.3yrs | データなし | データなし | |
| Chief Medical Officer | 3.1yrs | データなし | データなし | |
| President & Chief Scientific Officer of Fulgent Pharma | 1.6yrs | データなし | データなし |
4.3yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: FLGTの経営陣は 経験豊富 であると考えられます ( 4.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 8.1yrs | US$5.31m | 29.15% $ 172.5m | |
| Independent Non-Employee Director | 1.4yrs | US$625.60k | 0.0040% $ 23.5k | |
| Independent Director | 4.8yrs | US$270.50k | 0.062% $ 369.1k | |
| Independent Non-Employee Director | 1.8yrs | US$268.50k | 0.0080% $ 47.1k |
3.3yrs
平均在職期間
67yo
平均年齢
経験豊富なボード: FLGTの 取締役会 は 経験豊富 であると考えられます ( 3.3年の平均在任期間)。